Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Symbol
TARS
Shares outstanding
42,450,857 shares
Disclosed Ownership
1,188,624 shares
Ownership
2.8%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:15:06 UTC
Date of event
31 Dec 2025
Previous filing
15 May 2025

Sponsored

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 2.8% ownership in Tarsus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (TARS) on 31 Dec 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Tarsus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (TARS).
  • Disclosed ownership: 2.8%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 15 May 2025.
  • Current filing was accepted on 17 Feb 2026, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 2.8% 1,188,624 0 1,188,624 /s/ Kevin Tang Manager
KEVIN TANG 2.8% 1,188,624 0 1,188,624 /s/ Kevin Tang Self
TANG CAPITAL PARTNERS, LP 0.81% 345,686 0 345,686 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 1.8% 784,938 0 784,938 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0.1% 43,500 0 43,500 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0.04% 14,500 0 14,500 /s/ Kevin Tang Chief Executive Officer